This ad listing is expired.
The biotechnology market is hard, but it is exciting. Nonlinear advances in converging technologies such as AI, Synbio, ‘Omics, Cell & Gene Therapies, Robotics, and Processing will change our operations and our risk. Brinton Bio is focused on how to translate these changes into wise business decisions.
